Literature DB >> 1711971

Can we predict sudden cardiac death?

T Meinertz1, T Hofmann, M Zehender.   

Abstract

Up to now only 30 to 40% of patients who die suddenly can be identified as likely candidates before the event. Risk factors in these asymptomatic subjects include a familial history of coronary artery disease, high blood cholesterol levels, hypertension, smoking and, more importantly, an abnormal ECG at rest or during exercise. The predictive value of these abnormalities is too low to justify more detailed clinical investigations in most of these asymptomatic subjects. Exceptions might be the group of patients with multiple risk factors and competitive sportsmen. Sudden cardiac death is a well known complication in patients with hypertrophic and dilated cardiomyopathy. Risk factors in hypertrophic cardiomyopathy include a familial history of this disease, syncope and increasing age. Furthermore, in the adult, the presence of nonsustained episodes of ventricular tachycardia during Holter monitoring seems to indicate an increased risk of sudden cardiac death. In idiopathic dilated cardiomyopathy, the presence of frequent episodes of ventricular pairs and/or episodes of ventricular tachycardia during Holter monitoring, together with a reduced left ventricular ejection fraction, characterises the patient at risk of sudden cardiac death. In patients with coronary artery disease, the patient at risk of sudden cardiac death can be identified by investigating the following: coronary anatomy; global and regional left ventricular function; the presence of ischaemia during rest and/or exercise; the presence of late potentials, by means of the signal-averaged ECG; the presence of spontaneous ventricular arrhythmias (especially sustained and nonsustained ventricular tachycardia); and the results of electrophysiological testing. On the basis of these investigations, 3 subgroups can be distinguished: patients at low risk, medium risk, and high risk of sudden cardiac death.

Entities:  

Mesh:

Year:  1991        PMID: 1711971     DOI: 10.2165/00003495-199100412-00004

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  24 in total

1.  Predisposing factors in sudden cardiac death in Tecumseh, Michigan. A prospective study.

Authors:  B N Chiang; L V Perlman; M Fulton; L D Ostrander; F H Epstein
Journal:  Circulation       Date:  1970-01       Impact factor: 29.690

2.  Sudden unexpected death in patients with congestive heart failure: a second frontier.

Authors:  M Packer
Journal:  Circulation       Date:  1985-10       Impact factor: 29.690

3.  Sudden death and physical activity.

Authors:  I Vuori; M Mäkäräinen; A Jäskeläinen
Journal:  Cardiology       Date:  1978       Impact factor: 1.869

4.  The mural left anterior descending coronary artery, strenuous exercise and sudden death.

Authors:  A R Morales; R Romanelli; R J Boucek
Journal:  Circulation       Date:  1980-08       Impact factor: 29.690

5.  Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features.

Authors:  W McKenna; J Deanfield; A Faruqui; D England; C Oakley; J Goodwin
Journal:  Am J Cardiol       Date:  1981-03       Impact factor: 2.778

6.  Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study.

Authors:  B J Maron; D D Savage; J K Wolfson; S E Epstein
Journal:  Am J Cardiol       Date:  1981-08       Impact factor: 2.778

7.  Association between transient pulmonary congestion during acute myocardial infarction and high incidence of death in six months.

Authors:  E M Dwyer; H Greenberg; R B Case
Journal:  Am J Cardiol       Date:  1986-11-01       Impact factor: 2.778

8.  Prognostic usefulness of programmed ventricular stimulation in idiopathic dilated cardiomyopathy without symptomatic ventricular arrhythmias.

Authors:  S K Das; F Morady; L DiCarlo; J Baerman; R Krol; M De Buitleir; B Crevey
Journal:  Am J Cardiol       Date:  1986-11-01       Impact factor: 2.778

9.  Sudden death in patients with hypertrophic cardiomyopathy: characterization of 26 patients with functional limitation.

Authors:  B J Maron; W C Roberts; J E Edwards; H A McAllister; D D Foley; S E Epstein
Journal:  Am J Cardiol       Date:  1978-05-01       Impact factor: 2.778

10.  Relation of left ventricular function and prognosis in hypertrophic cardiomyopathy: an angiographic study.

Authors:  H Newman; D Sugrue; C M Oakley; J F Goodwin; W J McKenna
Journal:  J Am Coll Cardiol       Date:  1985-05       Impact factor: 24.094

View more
  2 in total

Review 1.  Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias.

Authors:  J Gill; R C Heel; A Fitton
Journal:  Drugs       Date:  1992-01       Impact factor: 9.546

Review 2.  Cibenzoline. A review of its pharmacological properties and therapeutic potential in arrhythmias.

Authors:  D W Harron; R N Brogden; D Faulds; A Fitton
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.